FAKTOR-OPTIONSSCHEIN - RECORDATI INDUSTRIA CHIMICA E FARMA | Market Closed - Börse Stuttgart 14:48:42 29/05/2024 BST | ||
| 7.75 EUR | -3.73% |
|
| Current month | -7.79% | ||
| 1 month | -3.36% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RECORDATI
| Date | Price | Change |
|---|---|---|
| 29/05/24 | 7.75 | -3.73% |
| 28/05/24 | 8.05 | -0.86% |
| 27/05/24 | 8.12 | +2.14% |
| 24/05/24 | 7.95 | -2.09% |
| 23/05/24 | 8.12 | -2.05% |
Delayed Quote Börse Stuttgart
Last update May 29, 2024 at 02:48 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | RECORDATI |
| Issuer | Morgan Stanley |
| WKN | MG0HJX |
| ISIN | DE000MG0HJX5 |
| Date issued | 20/03/2024 |
| Strike | 32.07 € |
| Maturity | Unlimited |
| Parity | 2.04 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 11.27 € |
|---|---|
| Lowest since issue | 7.75 € |
| Spread | 0.08 € |
| Spread % | 1.03% |
Company Profile
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceutical and OTC products (67.9%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.;
- medicines for rare diseases (32.1%).
Net sales are distributed geographically as follows: Italy (15%), Europe (58.5%), America (17.5%), Australasia (6.2%) and Africa (2.8%).
Sector
-
Consensus: Recordati
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
48.1
EUR
Average target price
52.24
EUR
Spread / Average Target
+8.61%
- Stock Market
- Certificates
- Certificat
